Bernet-Vegue L, Cantero-Gonzalez C, Sancho de Salas M, Parada D, Perin T, Quintero-Nino Z
Clin Transl Oncol. 2023; 26(5):1220-1228.
PMID: 38070048
PMC: 11026238.
DOI: 10.1007/s12094-023-03347-7.
de Gordoa K, Rodrigo-Calvo M, Archilla I, Lopez-Prades S, Diaz A, Tarragona J
Cancers (Basel). 2023; 15(22).
PMID: 38001742
PMC: 10670609.
DOI: 10.3390/cancers15225481.
Bernet L, Hardisson D, Rodrigo M, Cordoba A, Sancho M, Peg V
Clin Pathol. 2023; 16:2632010X231183693.
PMID: 37534372
PMC: 10392164.
DOI: 10.1177/2632010X231183693.
Martin-Salvago M, Sancho M, Lopez-Garcia M, Cano Jimenez A, Perez-Luque A, Alfaro L
Breast Cancer Res Treat. 2023; 200(2):203-215.
PMID: 37219637
PMC: 10241680.
DOI: 10.1007/s10549-023-06954-8.
Diaz-Mercedes S, Archilla I, Lahoz S, Rodrigo-Calvo M, Lopez-Prades S, Tarragona J
Cancers (Basel). 2022; 14(24).
PMID: 36551559
PMC: 9775901.
DOI: 10.3390/cancers14246072.
One Step Nucleic Acid Amplification (OSNA) Lysate Samples Are Suitable to Establish a Transcriptional Metastatic Signature in Patients with Early Stage Hormone Receptors-Positive Breast Cancer.
Gante I, Ribeiro J, Mendes J, Gomes A, Almeida V, Regateiro F
Cancers (Basel). 2022; 14(23).
PMID: 36497336
PMC: 9736102.
DOI: 10.3390/cancers14235855.
One-Step Nucleic Acid Amplification System in Comparison to the Intraoperative Frozen Section and Definitive Histological Examination Among Breast Cancer Patients: A Retrospective Survival Study.
Bertozzi S, Londero A, Bulfoni M, Seriau L, Agakiza D, Pasqualucci A
Front Oncol. 2022; 12:847858.
PMID: 35664761
PMC: 9158526.
DOI: 10.3389/fonc.2022.847858.
Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer: a systematic review.
Cuadras M, Planas J, Celma A, Regis L, de Torres I, Semidey M
BMC Cancer. 2022; 22(1):357.
PMID: 35366849
PMC: 8976947.
DOI: 10.1186/s12885-022-09355-0.
Detection of lymph node metastasis in non-small cell lung cancer using the new system of one-step nucleic acid amplification assay.
Ose N, Takeuchi Y, Sakamaki Y, Kadota Y, Urasaki K, Tsuji H
PLoS One. 2022; 17(3):e0265603.
PMID: 35312731
PMC: 8936453.
DOI: 10.1371/journal.pone.0265603.
A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large-scale, multicenter cohort study.
Osako T, Matsuura M, Yotsumoto D, Takayama S, Kaneko K, Takahashi M
Cancer. 2022; 128(10):1913-1920.
PMID: 35226357
PMC: 9311203.
DOI: 10.1002/cncr.34144.
Can one-step nucleic acid amplification assay predict four or more positive axillary lymph node involvement in breast cancer patients: a single-centre retrospective study.
Kenny R, Wong G, Gould L, Odofin O, Bowyer R, Sotheran W
Ann R Coll Surg Engl. 2021; 104(3):216-220.
PMID: 34928727
PMC: 10334894.
DOI: 10.1308/rcsann.2021.0154.
Sentinel lymph node biopsy with one-step nucleic acid assay relegates the need for preoperative ultrasound-guided biopsy staging of the axilla in patients with early stage breast cancer.
Inua B, Fung V, Al-Shurbasi N, Howells S, Hatsiopoulou O, Somarajan P
Mol Clin Oncol. 2021; 14(3):51.
PMID: 33604041
PMC: 7849070.
DOI: 10.3892/mco.2021.2213.
Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study.
Vieites B, Lopez-Garcia M, Martin-Salvago M, Ramirez-Tortosa C, Rezola R, Sancho M
Clin Transl Oncol. 2021; 23(7):1377-1385.
PMID: 33517542
PMC: 8192368.
DOI: 10.1007/s12094-020-02530-4.
OPTimizing Irradiation through Molecular Assessment of Lymph node (OPTIMAL): a randomized open label trial.
Algara Lopez M, Rodriguez Garcia E, Beato Tortajada I, Martinez Arcelus F, Salinas Ramos J, Rodriguez Garrido J
Radiat Oncol. 2020; 15(1):229.
PMID: 33008422
PMC: 7531133.
DOI: 10.1186/s13014-020-01672-7.
External validation of a prognostic model based on total tumor load of sentinel lymph node for early breast cancer patients.
Pinero-Madrona A, Ripoll-Orts F, Sanchez-Mendez J, Chaves-Benito A, Gomez-de la Barcena M, Calatrava-Fons A
Breast Cancer Res Treat. 2020; 181(2):339-345.
PMID: 32253684
PMC: 7188708.
DOI: 10.1007/s10549-020-05623-4.
Budget Impact Analysis of Molecular Lymph Node Staging Versus Conventional Histopathology Staging in Colorectal Carcinoma.
Diaz-Mercedes S, Archilla I, Camps J, de Lacy A, Gorostiaga I, Momblan D
Appl Health Econ Health Policy. 2019; 17(5):655-667.
PMID: 31115896
PMC: 6748889.
DOI: 10.1007/s40258-019-00482-7.
Performance of a new system using a one-step nucleic acid amplification assay for detecting lymph node metastases in breast cancer.
Shimazu K, Tanei T, Tamaki Y, Saeki T, Osaki A, Hasebe T
Med Oncol. 2019; 36(6):54.
PMID: 31062258
DOI: 10.1007/s12032-019-1277-x.
One-step nucleic acid amplification: the possible value in assessing sentinel lymph node metastasis during mastectomy.
Hunter-Smith A, Rayter Z
Breast Cancer (Dove Med Press). 2018; 10:13-21.
PMID: 29416374
PMC: 5790072.
DOI: 10.2147/BCTT.S113737.
Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay.
Fung V, Kohlhardt S, Vergani P, Zardin G, Williams N
Mol Clin Oncol. 2017; 7(5):755-762.
PMID: 29142748
PMC: 5666659.
DOI: 10.3892/mco.2017.1404.
A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients.
Osako T, Iwase T, Ushijima M, Yonekura R, Ohno S, Akiyama F
Br J Cancer. 2017; 117(10):1470-1477.
PMID: 28910822
PMC: 5680460.
DOI: 10.1038/bjc.2017.311.